Mehmet Eren Ahsen

Prof. Mehmet Eren Ahsen

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
BLBojan Losic
Bojan Losic
ACAmanda J. Craig
Amanda J. Craig
CVCarlos Villacorta-Martin
Carlos Villacorta-Martin
SMSebastiao N. Martins-Filho
Sebastiao N. Martins-Filho
NANicholas Akers
Nicholas Akers
AVAugusto Villanueva
Augusto Villanueva
Clonal evolution of a tumor ecosystem depends on different selection pressures that are principally immune and treatment mediated. We integrate RNA-seq, DNA sequencing, TCR-seq and SNP array data across multiple regions of liver cancer specimens to map spatio-temporal interactions between cancer and immune cells. We investigate how these interactions reflect intra-tumor heterogeneity (ITH) by correlating regional neo-epitope and viral antigen burden with the regional adaptive immune response. Regional expression of passenger mutations dominantly recruits adaptive responses as opposed to hepatitis B virus and cancer-testis antigens. We detect different clonal expansion of the adaptive immune system in distant regions of the same tumor. An ITH-based gene signature improves single-biopsy patient survival predictions and an expression survey of 38,553 single cells across 7 regions of 2 patients further reveals heterogeneity in liver cancer. These data quantify transcriptomic ITH and how the different components of the HCC ecosystem interact during cancer evolution.

17 June 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MMMichael P. Menden
Michael P. Menden
DWDennis Wang
Dennis Wang
MMMike J. Mason
Mike J. Mason
BSBence Szalai
Bence Szalai
KBKrishna C. Bulusu
Krishna C. Bulusu
JSJulio Saez-Rodriguez
Julio Saez-Rodriguez
The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop resistance that might be overcome with drug combinations. However, the number of possible combinations is vast, necessitating data-driven approaches to find optimal patient-specific treatments. Here we report AstraZeneca’s large drug combination dataset, consisting of 11,576 experiments from 910 combinations across 85 molecularly characterized cancer cell lines, and results of a DREAM Challenge to evaluate computational strategies for predicting synergistic drug pairs and biomarkers. 160 teams participated to provide a comprehensive methodological development and benchmarking. Winning methods incorporate prior knowledge of drug-target interactions. Synergy is predicted with an accuracy matching biological replicates for >60% of combinations. However, 20% of drug combinations are poorly predicted by all methods. Genomic rationale for synergy predictions are identified, including ADAM17 inhibitor antagonism when combined with PIK3CB/D inhibition contrasting to synergy when combined with other PI3K-pathway inhibitors in PIK3CA mutant cells.

16 May 2019 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
SKSarah L. Kerns
Sarah L. Kerns
LFLaura Fachal
Laura Fachal
LDLeila Dorling
Leila Dorling
GBGillian C Barnett
Gillian C Barnett
ABAndrea Baran
Andrea Baran
CWCatharine Mary Louise West
Catharine Mary Louise West
A total of 10%–20% of patients develop long-term toxicity following radiotherapy for prostate cancer. Identification of common genetic variants associated with susceptibility to radiotoxicity might improve risk prediction and inform functional mechanistic studies. We conducted an individual patient data meta-analysis of six genome-wide association studies (n = 3871) in men of European ancestry who underwent radiotherapy for prostate cancer. Radiotoxicities (increased urinary frequency, decreased urinary stream, hematuria, rectal bleeding) were graded prospectively. We used grouped relative risk models to test associations with approximately 6 million genotyped or imputed variants (time to first grade 2 or higher toxicity event). Variants with two-sided Pmeta less than 5 × 10−8 were considered statistically significant. Bayesian false discovery probability provided an additional measure of confidence. Statistically significant variants were evaluated in three Japanese cohorts (n = 962). All statistical tests were two-sided. Meta-analysis of the European ancestry cohorts identified three genomic signals: single nucleotide polymorphism rs17055178 with rectal bleeding (Pmeta = 6.2 × 10−10), rs10969913 with decreased urinary stream (Pmeta = 2.9 × 10−10), and rs11122573 with hematuria (Pmeta = 1.8 × 10−8). Fine-scale mapping of these three regions was used to identify another independent signal (rs147121532) associated with hematuria (Pconditional = 4.7 × 10−6). Credible causal variants at these four signals lie in gene-regulatory regions, some modulating expression of nearby genes. Previously identified variants showed consistent associations (rs17599026 with increased urinary frequency, rs7720298 with decreased urinary stream, rs1801516 with overall toxicity) in new cohorts. rs10969913 and rs17599026 had similar effects in the photon-treated Japanese cohorts. This study increases the understanding of the architecture of common genetic variants affecting radiotoxicity, points to novel radio-pathogenic mechanisms, and develops risk models for testing in clinical studies. Further multinational radiogenomics studies in larger cohorts are worthwhile.

1 September 2017 in Applied and Computational Harmonic Analysis
Verified
Journal Article
Open access
Mehmet Eren AhsenMehmet Eren Ahsen
Mehmet Eren Ahsen
MVM. Vidyasagar
M. Vidyasagar
In compressed sensing, in order to recover a sparse or nearly sparse vector from possibly noisy measurements, the most popular approach is ℓ1-norm minimization. Upper bounds for the ℓ2-norm of the error between the true and estimated vectors are given in [1] and reviewed in [2], while bounds for the ℓ1-norm are given in [3]. When the unknown vector is not conventionally sparse but is “group sparse” instead, a variety of alternatives to the ℓ1-norm have been proposed in the literature, including the group LASSO, sparse group LASSO, and group LASSO with tree structured overlapping groups. However, no error bounds are available for any of these modified objective functions. In the present paper, a unified approach is presented for deriving upper bounds on the error between the true vector and its approximation, based on the notion of decomposable and γ-decomposable norms. The bounds presented cover all of the norms mentioned above, and also provide a guideline for choosing norms in future to accommodate alternate forms of sparsity

1 December 2022 in Information Systems Research
Verified
Journal Article
Closed access
WHWencui Han
Wencui Han
XWXunyi Wang
Xunyi Wang
Mehmet Eren AhsenMehmet Eren Ahsen
Mehmet Eren Ahsen
SWSunil Wattal
Sunil Wattal
The rise of the sharing economy has disrupted traditional industries and has had many unforeseen societal impacts. This has sparked policy debates on whether and how the sharing economy should be regulated to promote the healthy growth of such markets. In this research, we examine the impact of platform self-regulations in the context of the home-sharing market. Using policy changes that reduce the number of Airbnb listings, we empirically test the impact of platform self-regulations on crime rates. Our results suggest that a reduction in Airbnb listings resulting from platform self-regulations leads to a reduction in crime. We further study the impact of these policy changes on different types of crime and find that these self-regulations lead to a reduction in incidents of crime such as assault, robbery, and burglary but an increase in theft incidents. In addition, we find that the impact of these policies varies based on the neighborhood’s characteristics, such as income, housing price, and population. This research contributes to our understanding of the societal impacts of the sharing economy and the impact of platform self-regulation. Our findings also provide empirical evidence to inform policy making.

18 September 2020 in eLife
Verified
Journal Article
Open access
JDJennifer EL Diaz
Jennifer EL Diaz
Mehmet Eren AhsenMehmet Eren Ahsen
Mehmet Eren Ahsen
TSThomas Schaffter
Thomas Schaffter
XCXintong Chen
Xintong Chen
RRRonald B Realubit
Ronald B Realubit
GSGustavo Stolovitzky
Gustavo Stolovitzky
Our ability to discover effective drug combinations is limited, in part by insufficient understanding of how the transcriptional response of two monotherapies results in that of their combination. We analyzed matched time course RNAseq profiling of cells treated with single drugs and their combinations and found that the transcriptional signature of the synergistic combination was unique relative to that of either constituent monotherapy. The sequential activation of transcription factors in time in the gene regulatory network was implicated. The nature of this transcriptional cascade suggests that drug synergy may ensue when the transcriptional responses elicited by two unrelated individual drugs are correlated. We used these results as the basis of a simple prediction algorithm attaining an AUROC of 0.77 in the prediction of synergistic drug combinations in an independent dataset.